Page last updated: 2024-09-03

1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and ceruletide

1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone has been researched along with ceruletide in 1 studies

Compound Research Comparison

Studies
(1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)
Trials
(1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)
Recent Studies (post-2010)
(1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)
Studies
(ceruletide)
Trials
(ceruletide)
Recent Studies (post-2010) (ceruletide)
26053,00291645

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bourin, M; Colombel, MC; Malinge, M; Vasar, E1

Other Studies

1 other study(ies) available for 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and ceruletide

ArticleYear
Cholecystokinin receptor agonists block the jumping behaviour precipitated in morphine-dependent mice by naloxone.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999, Volume: 9, Issue:1-2

    Topics: Animals; Ceruletide; Devazepide; Dose-Response Relationship, Drug; Hormone Antagonists; Male; Mice; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Pyrazoles; Receptors, Cholecystokinin; Substance Withdrawal Syndrome; Tetragastrin; Thiorphan

1999